Treatment of intracranial aneurysms using the new Surpass Evolve flow diverter: Safety outcomes and six-month imaging follow-up - 10/02/22
pages | 7 |
Iconographies | 3 |
Vidéos | 0 |
Autres | 0 |
Graphical abstract |
Highlights |
• | This study reports the results with the longest radiographic follow-up of the new Surpass Evolve flow diverter. |
• | Our results demonstrate encouraging technical success and good radiological outcomes. |
• | Favorable aneurysm occlusion (O’Kelly Marotta grading scale C-D) at six month follow-up was achieved in 21/27 (78%) aneurysms. |
Abstract |
Background and purpose |
Several studies have reported good long-term results in the occlusion of intracranial aneurysms with flow diverter treatment. The aim of this study was to report the safety and six-month follow-up outcomes using the new Surpass Evolve flow diverter in the treatment of intracranial aneurysms.
Materials and methods |
Consecutive patients with intracranial aneurysm treated with Surpass Evolve flow diverter in two high-volume neurovascular centers between May 2019 and January 2020 were retrospectively reviewed. Procedure-related complications, aneurysm occlusion (O’Kelly-Marotta grading scale), and clinical outcomes were assessed.
Results |
Twenty-nine patients with 30 aneurysms were included in the study. Favorable aneurysm occlusion (O’Kelly Marotta grading scale C-D) at six-month follow-up was achieved in 21/27 (78%) aneurysms. No clinical procedure related thromboembolic complications were encountered. Twenty-three out of 24 patients with unruptured aneurysms treated with Surpass Evolve remained clinically intact at clinical follow-up. There was one fatal hemorrhagic procedure-related complication (3%). In five patients with ruptured aneurysms, no early or late rebleeds occurred from the aneurysms.
Conclusions |
Surpass Evolve FD worked technically well with no intraprocedural thromboembolic complications and occlusion rates comparable to other FDs.
Le texte complet de cet article est disponible en PDF.Keywords : Aneurysm, Intracranial, Endovascular, Flow diverter, Surpass Evolve
Abbreviations : ACT, FD, mRS, OKM
Plan
Vol 49 - N° 1
P. 80-86 - janvier 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?